Patentability of antibodies in the artificial intelligence era
Trends in Biotechnology · 2026-05
DOI: 10.1016/j.tibtech.2026.04.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-05. Verfasst von Yu Yao und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Law, China Jiliang University, Hangzhou 310018, China. Die Arbeit nennt 15 Literaturangaben. Gefördert von: Fundamental Research Funds for the Provincial Universities of Zhejiang Province.
Abstract (Originalsprache)
Artificial intelligence can accelerate antibody discovery, potentially reshaping how inventions must be disclosed while raising standards for truly creative breakthroughs. This science and society article advocates modernizing 'undue experimentation' criteria, giving appropriate evidentiary weight to in silico data, and redefining a skilled person's capabilities, thereby rewarding genuine human inventions while preserving patent incentives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Law, China Jiliang University, Hangzhou 310018, China.
- School of Law, China Jiliang University, Hangzhou 310018, China. Electronic address: itlaw_yang@163.com.
Förderung
- Fundamental Research Funds for the Provincial Universities of Zhejiang Province
Zitieren
APA
Yao, Y., & Yang, F. (2026). Patentability of antibodies in the artificial intelligence era. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.04.014
Vancouver
Yao Y, Yang F. Patentability of antibodies in the artificial intelligence era. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.04.014
BibTeX
@article{Yao2026,
author = {Yao, Yu and Yang, Fei},
title = {Patentability of antibodies in the artificial intelligence era},
journal = {Trends in Biotechnology},
year = {2026},
doi = {10.1016/j.tibtech.2026.04.014}
}
EUVIMED